Recently added

Understanding tumour growth variability in breast cancer xenograft models identifies PARP inhibition resistance biomarkers

Voulgarelis, Dimitrios; Forment, Josep; Polychronopoulos, Dimitris; Cohen-Setton, Jake; Bender, Andreas; Herencia Ropero, Andrea (Nature Portfolio, 2024-11-18)

First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study

Piedra, Aida; Martinez-Recio, Sergio; Morán, Teresa; Recuero-Borau, Jordi; Hernandez, Ainhoa; Arriola, Edurne; Callejo, Ana; Iranzo, Patricia; FELIP, ENRIQUETA (Frontiers Media, 2024-12-17)

Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol

Salazar, Juliana; Arranz, Maria J; BAUTISTA, FRANCISCO JOSE; Martin-Broto, Javier; Martinez-Garcia, Jeronimo; Martinez-Trufero, Javier; Valverde, Claudia María (MDPI, 2024-12-12)

Loss of Lkb1 cooperates with BrafV600E and ultraviolet radiation, increasing melanoma multiplicity and neural-like dedifferentiation

Mc Grail Fernández, Kimberley; González Sánchez, Elena; Granado Martínez, Paula; Orsenigo, Roberto; Ding, Yuxin; Ferrer Fábrega, Berta; Recio, Juan Angel; Hernandez-Losa, Javier; MUÑOZ COUSELO, EVA; Garcia-Patos Briones, Vicente (Wiley, 2024)

Cyclophilin D plays a critical role in the survival of senescent cells

Protasoni, Margherita; López Polo, Vanessa; Stephan-Otto Attolini, Camille; Herranz Martín, Nicolás; Brandariz, Julian; Mateo, Joaquin (EMBO Press, 2024-12-02)

Scientia. Department of Health Digital Information Depot

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Understanding tumour growth variability in breast cancer xenograft models identifies PARP inhibition resistance biomarkers

First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study

Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol

Loss of Lkb1 cooperates with BrafV600E and ultraviolet radiation, increasing melanoma multiplicity and neural-like dedifferentiation

Cyclophilin D plays a critical role in the survival of senescent cells

Scientia. Department of Health Digital Information Depot

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Understanding tumour growth variability in breast cancer xenograft models identifies PARP inhibition resistance biomarkers ﻿

First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study ﻿

Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol ﻿

Loss of Lkb1 cooperates with BrafV600E and ultraviolet radiation, increasing melanoma multiplicity and neural-like dedifferentiation ﻿

Cyclophilin D plays a critical role in the survival of senescent cells ﻿

Understanding tumour growth variability in breast cancer xenograft models identifies PARP inhibition resistance biomarkers

First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study

Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol

Loss of Lkb1 cooperates with BrafV600E and ultraviolet radiation, increasing melanoma multiplicity and neural-like dedifferentiation

Cyclophilin D plays a critical role in the survival of senescent cells